CONCLUSIONS : These data support the hypothesis that the common polymorphism at position -93 in the core promoter of MLH1 defines a risk allele for the development of cancer after methylating chemotherapy for Hodgkin lymphoma .
O O O O O O O O O O O O O O O O O O O B-GeneOrGeneProduct O O O O O O O O B-DiseaseOrPhenotypicFeature O O O O B-DiseaseOrPhenotypicFeature I-DiseaseOrPhenotypicFeature O